Question 1

What are the different dosing strategies of regorafenib being tested in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC clinical trial (NCT02835924). Contact the study team or your healthcare provider for specific answers.

Question 2

How does regorafenib compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC clinical trial (NCT02835924). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC clinical trial (NCT02835924). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC clinical trial (NCT02835924). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or procedures will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC clinical trial (NCT02835924). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks I should be aware of before joining this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC clinical trial (NCT02835924). Contact the study team or your healthcare provider for specific answers.

What this study is about